Published in Melanoma Res on October 01, 2009
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma. Br J Cancer (2016) 1.41
TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. Br J Cancer (2011) 0.89
Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma. J Transl Med (2012) 0.88
Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo. Radiol Oncol (2016) 0.79
HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature. J Exp Clin Cancer Res (2014) 0.79
Dermoscopic patterns of melanoma metastases: interobserver consistency and accuracy for metastasis recognition. Br J Dermatol (2013) 0.78
CT of the skin and subcutaneous tissues. Emerg Radiol (2012) 0.75
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol (2007) 1.69
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. Haematologica (2007) 1.66
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J (2011) 1.66
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort. J Transl Med (2014) 1.59
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol (2002) 1.54
Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study. Eur J Dermatol (2011) 1.43
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program. Cancer Invest (2014) 1.06
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases. Dermatol Surg (2009) 1.03
Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol (2011) 1.01
The Sézary syndrome: hematologic criteria. Hematol Oncol Clin North Am (2003) 0.96
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. Melanoma Res (2010) 0.95
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. J Clin Oncol (2013) 0.92
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption. Dermatol Ther (2010) 0.91
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme. J Exp Clin Cancer Res (2014) 0.89
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J Invest Dermatol (2009) 0.89
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. Cancer (2005) 0.88
Functional and phenotypical impairment of polymorphonuclear cells in atopic dermatitis: an additional cause for the known susceptibility to infections?. Dermatology (2012) 0.85
Acute digital gangrene in a long-term dialysis patient -- a diagnostic challenge. Med Sci Monit (2002) 0.84
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma. Dermatology (2013) 0.83
Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum. Int Wound J (2012) 0.82
RT-PCR tyrosinase expression in the peripheral blood of melanoma patients. Expert Rev Mol Diagn (2004) 0.81
Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome. Dermatology (2006) 0.81
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. Anticancer Drugs (2004) 0.80
Electrochemotherapy in non-melanoma head and neck skin cancers: a three-center experience and review of the literature. G Ital Dermatol Venereol (2015) 0.80
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol (2014) 0.80
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement. Acta Derm Venereol (2016) 0.79
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. Pigment Cell Melanoma Res (2011) 0.79
Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. J Clin Oncol (2012) 0.79
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. Int J Cancer (2014) 0.79
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study. Dermatol Surg (2006) 0.78
Cutaneous melanoma metastases arising on a split-skin graft donor site. Dermatol Surg (2009) 0.78
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide (2012) 0.77
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prev (2012) 0.77
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. Melanoma Res (2007) 0.77
Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases. J Am Acad Dermatol (2003) 0.77
Prognostic differences across sexes in melanoma patients: what has changed from the past? Melanoma Res (2014) 0.77
Squamocellular Carcinoma of the Skin: Clinicopathological Features Predicting the Involvement of the Surgical Margins and Review of the Literature. Dermatology (2016) 0.77
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients. Eur J Dermatol (2012) 0.77
Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value. J Dermatol Sci (2012) 0.77
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model. Free Radic Biol Med (2013) 0.77
Eruptive dermal clear cell desmo-plastic mesenchymal tumors with perivascular myoid differentiation in a young boy. A clinical, histopathologic, immunohistochemical and electron microscopy study of 17 lesions. J Cutan Pathol (2013) 0.76
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost (2015) 0.76
Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study. Melanoma Res (2004) 0.76
Cutaneous B-cell neoplasms mimicking granulomatous rosacea or rhinophyma. Arch Dermatol (2012) 0.76
Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther (2012) 0.76
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. Eur J Dermatol (2011) 0.75
A retrospective analysis of the costs and management of genital warts in Italy. BMC Infect Dis (2013) 0.75
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. Int J Dermatol (2013) 0.75
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients? J Clin Oncol (2007) 0.75
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data. Melanoma Res (2004) 0.75
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus. J Dermatolog Treat (2010) 0.75
Flow cytometry immunophenotyping in mycosis fungoides. J Am Acad Dermatol (2008) 0.75
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction. G Ital Dermatol Venereol (2012) 0.75
Atopic dermatitis in a phenylketonuric untreated patient. Int J Dermatol (2013) 0.75
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models. J Biomed Nanotechnol (2015) 0.75
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. Dermatol Ther (2010) 0.75
Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma. Melanoma Res (2015) 0.75
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp. Am J Dermatopathol (2010) 0.75